134 related articles for article (PubMed ID: 27986603)
1. New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Calpena AC; Folch J; Camins A; García ML
Nanomedicine; 2017 Apr; 13(3):1171-1182. PubMed ID: 27986603
[TBL] [Abstract][Full Text] [Related]
2. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
3. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
Sánchez-López E; Egea MA; Cano A; Espina M; Calpena AC; Ettcheto M; Camins A; Souto EB; Silva AM; García ML
Colloids Surf B Biointerfaces; 2016 Sep; 145():241-250. PubMed ID: 27187188
[TBL] [Abstract][Full Text] [Related]
4. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
[TBL] [Abstract][Full Text] [Related]
5. Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery.
Jin SG; Yousaf AM; Son MW; Jang SW; Kim DW; Kim JO; Yong CS; Kim JH; Choi HG
Arch Pharm Res; 2015 Feb; 38(2):216-22. PubMed ID: 24988989
[TBL] [Abstract][Full Text] [Related]
6. Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.
Ettcheto M; Sánchez-López E; Pons L; Busquets O; Olloquequi J; Beas-Zarate C; Pallas M; García ML; Auladell C; Folch J; Camins A
Redox Biol; 2017 Oct; 13():345-352. PubMed ID: 28646794
[TBL] [Abstract][Full Text] [Related]
7. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
[TBL] [Abstract][Full Text] [Related]
8. Gel network comprising UV crosslinked PLGA-b-PEG-MA nanoparticles for ibuprofen topical delivery.
Eroglu I; Gultekinoglu M; Bayram C; Erikci A; Ciftci SY; Ayse Aksoy E; Ulubayram K
Pharm Dev Technol; 2019 Nov; 24(9):1144-1154. PubMed ID: 31298072
[TBL] [Abstract][Full Text] [Related]
9. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
11. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer's Disease After Implantation of VEGF-loaded PLGA Nanospheres.
Herran E; Perez-Gonzalez R; Igartua M; Pedraz JL; Carro E; Hernandez RM
Curr Alzheimer Res; 2015; 12(10):932-40. PubMed ID: 26502822
[TBL] [Abstract][Full Text] [Related]
13. Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer's disease: evidence of potential intranasal brain targeting.
Wen MM; Ismail NIK; Nasra MMA; El-Kamel AH
Drug Deliv; 2021 Dec; 28(1):1188-1203. PubMed ID: 34121565
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
[TBL] [Abstract][Full Text] [Related]
15. Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films.
Lee JH; Go AK; Oh SH; Lee KE; Yuk SH
Biomaterials; 2005 Feb; 26(6):671-8. PubMed ID: 15282145
[TBL] [Abstract][Full Text] [Related]
16. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
17. VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease.
Herrán E; Pérez-González R; Igartua M; Pedraz JL; Carro E; Hernández RM
J Control Release; 2013 Aug; 170(1):111-9. PubMed ID: 23684689
[TBL] [Abstract][Full Text] [Related]
18. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
19. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
20. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
